Orbital Therapy debuts artifact-reducing insert for breast imaging

Breast cancer technology provider Orbital Therapy has announced the availability of its artifact-reducing insert for its ClearVue prone breast platform.

According to the Bedford, Mass.-based company, the patent-pending design of the new insert reduces the shadow effect projected through the breast to be treated, generated by the CT reconstruction process, resulting in a cleaner CT image of the breast.

 

Around the web

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.